Correlation Between LIWANLI Innovation and Alar Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both LIWANLI Innovation and Alar Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining LIWANLI Innovation and Alar Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between LIWANLI Innovation Co and Alar Pharmaceuticals, you can compare the effects of market volatilities on LIWANLI Innovation and Alar Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in LIWANLI Innovation with a short position of Alar Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of LIWANLI Innovation and Alar Pharmaceuticals.

Diversification Opportunities for LIWANLI Innovation and Alar Pharmaceuticals

-0.13

Correlation Coefficient

LIWANLI Innovation  Alar Pharmaceuticals

Good diversification

The 3 months correlation between LIWANLI and Alar is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding LIWANLI Innovation Co and Alar Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alar Pharmaceuticals and LIWANLI Innovation is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on LIWANLI Innovation Co are associated (or correlated) with Alar Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alar Pharmaceuticals has no effect on the direction of LIWANLI Innovation i.e., LIWANLI Innovation and Alar Pharmaceuticals go up and down completely randomly.

Pair Corralation between LIWANLI Innovation and Alar Pharmaceuticals

Assuming the 90 days trading horizon LIWANLI Innovation Co is expected to under-perform the Alar Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, LIWANLI Innovation Co is 1.48 times less risky than Alar Pharmaceuticals. The stock trades about -0.08 of its potential returns per unit of risk. The Alar Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  14,000  in Alar Pharmaceuticals on December 21, 2024 and sell it today you would earn a total of  500.00  from holding Alar Pharmaceuticals or generate 3.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

LIWANLI Innovation Co  vs.  Alar Pharmaceuticals

LIWANLI Innovation

Risk-Adjusted Performance

Very Weak

Over the last 90 days LIWANLI Innovation Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Alar Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Alar Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Alar Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with LIWANLI Innovation and Alar Pharmaceuticals

The main advantage of trading using opposite LIWANLI Innovation and Alar Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if LIWANLI Innovation position performs unexpectedly, Alar Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alar Pharmaceuticals will offset losses from the drop in Alar Pharmaceuticals' long position.

The idea behind LIWANLI Innovation Co and Alar Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.